17
Participants
Start Date
January 31, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
February 28, 2011
BN83495 (Cohort 1)
20 mg daily BN83495 for 28 days
BN83495 (Cohort 2)
40 mg daily BN83495 for 28 days
BN83495 (Cohort 3)
60 mg daily BN83495 for 28 days
Johns Hopkins University Medical Center, Baltimore
Duke University Medical Center United States, Durham
University of Wisconsin Hospital and Clinics, Madison
Lead Sponsor
Ipsen
INDUSTRY